Symap Medical Ltd. Closes Largest Financing Round In Renal Denervation Field
12/07/21, 7:30 AM
Location
suzhou
SyMap Medical (SyMap) announced its latest financing round of nearly $100 million led by Primavera Capital and VMS Group, with the participation of existing investors Simiao Equity Investment and Sequoia Capital China. CEC Capital served as the exclusive financial advisor for this transaction.